Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP
Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydro...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2006-06, Vol.16 (12), p.3175-3179 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3179 |
---|---|
container_issue | 12 |
container_start_page | 3175 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 16 |
creator | COX, Christopher D TORRENT, Maricel LOBELL, Robert B WEIKANG TAO SOUTH, Vicki J KOHL, Nancy E YOUWEI YAN KUO, Lawrence C PRUEKSARITANONT, Thomayant SLAUGHTER, Donald E CHUNZE LI MAHAN, Elizabeth BRESLIN, Michael J BING LU HARTMAN, George D MARIANO, Brenda J WHITMAN, David B COLEMAN, Paul J BUSER, Carolyn A WALSH, Eileen S HAMILTON, Kelly SCHABER, Michael D |
description | Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound. |
doi_str_mv | 10.1016/j.bmcl.2006.03.040 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67938098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67938098</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</originalsourceid><addsrcrecordid>eNqFUctqFTEYDqLY0-oLuJBslArN-GeSycy4k-KNFixUwV1IMhlPTjOXJhnk-GK-njl24CxdJR98N_4PoRcUCgpUvN0VejC-KAFEAawADo_QhnLBCeNQPUYbaAWQpuU_TtBpjDsAyoHzp-iECgGMVWKD_ly50UY34ji7sfMWz2FKNuPzq9ubN9iNW6ddmkIs8I0KCfN3-DaFxaQlWKJVtB3usv7niKceV0T5u71Xgxsnwi4q0jkV9p7wf9_tvgvTvA_q9-RtxCriOUeN6QL_UskGEie_6NzgmHnwTFuLh4ySM_hu7ZqrPUNPeuWjfb6-Z-j7xw_fLj-T66-fvly-vyaGl00ipbCq0hxAK860AdNVPVN1b63lilVt2auyyxha3VMlyroySjNuRN0bZkvLztDrB998l_vFxiQHF431Xo12WqIUdcsaaJv_EmlNRVPXVSaWD0QTphiD7eUc3JDvJCnIw65yJw-7ysOuEpjMu2bRy9V90YPtjpJ1yEx4tRJUNMr3QY3GxSMvJzeNqNlfEgev3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17168775</pqid></control><display><type>article</type><title>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>COX, Christopher D ; TORRENT, Maricel ; LOBELL, Robert B ; WEIKANG TAO ; SOUTH, Vicki J ; KOHL, Nancy E ; YOUWEI YAN ; KUO, Lawrence C ; PRUEKSARITANONT, Thomayant ; SLAUGHTER, Donald E ; CHUNZE LI ; MAHAN, Elizabeth ; BRESLIN, Michael J ; BING LU ; HARTMAN, George D ; MARIANO, Brenda J ; WHITMAN, David B ; COLEMAN, Paul J ; BUSER, Carolyn A ; WALSH, Eileen S ; HAMILTON, Kelly ; SCHABER, Michael D</creator><creatorcontrib>COX, Christopher D ; TORRENT, Maricel ; LOBELL, Robert B ; WEIKANG TAO ; SOUTH, Vicki J ; KOHL, Nancy E ; YOUWEI YAN ; KUO, Lawrence C ; PRUEKSARITANONT, Thomayant ; SLAUGHTER, Donald E ; CHUNZE LI ; MAHAN, Elizabeth ; BRESLIN, Michael J ; BING LU ; HARTMAN, George D ; MARIANO, Brenda J ; WHITMAN, David B ; COLEMAN, Paul J ; BUSER, Carolyn A ; WALSH, Eileen S ; HAMILTON, Kelly ; SCHABER, Michael D</creatorcontrib><description>Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2006.03.040</identifier><identifier>PMID: 16603356</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Alkylation ; Allosteric Site ; Amination ; Animals ; Antineoplastic agents ; Biological and medical sciences ; Crystallography, X-Ray ; Dogs ; Drug Design ; General aspects ; Hydroxylation ; Kinesin - antagonists & inhibitors ; Kinesin - chemistry ; Kinesin - metabolism ; Medical sciences ; Mitosis ; Models, Molecular ; Molecular Structure ; Pharmacology. Drug treatments ; Pyrazoles - chemical synthesis ; Pyrazoles - chemistry ; Pyrazoles - pharmacokinetics ; Pyrazoles - pharmacology ; Solubility ; Structure-Activity Relationship ; Water</subject><ispartof>Bioorganic & medicinal chemistry letters, 2006-06, Vol.16 (12), p.3175-3179</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</citedby><cites>FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17758867$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16603356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>COX, Christopher D</creatorcontrib><creatorcontrib>TORRENT, Maricel</creatorcontrib><creatorcontrib>LOBELL, Robert B</creatorcontrib><creatorcontrib>WEIKANG TAO</creatorcontrib><creatorcontrib>SOUTH, Vicki J</creatorcontrib><creatorcontrib>KOHL, Nancy E</creatorcontrib><creatorcontrib>YOUWEI YAN</creatorcontrib><creatorcontrib>KUO, Lawrence C</creatorcontrib><creatorcontrib>PRUEKSARITANONT, Thomayant</creatorcontrib><creatorcontrib>SLAUGHTER, Donald E</creatorcontrib><creatorcontrib>CHUNZE LI</creatorcontrib><creatorcontrib>MAHAN, Elizabeth</creatorcontrib><creatorcontrib>BRESLIN, Michael J</creatorcontrib><creatorcontrib>BING LU</creatorcontrib><creatorcontrib>HARTMAN, George D</creatorcontrib><creatorcontrib>MARIANO, Brenda J</creatorcontrib><creatorcontrib>WHITMAN, David B</creatorcontrib><creatorcontrib>COLEMAN, Paul J</creatorcontrib><creatorcontrib>BUSER, Carolyn A</creatorcontrib><creatorcontrib>WALSH, Eileen S</creatorcontrib><creatorcontrib>HAMILTON, Kelly</creatorcontrib><creatorcontrib>SCHABER, Michael D</creatorcontrib><title>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.</description><subject>Alkylation</subject><subject>Allosteric Site</subject><subject>Amination</subject><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Crystallography, X-Ray</subject><subject>Dogs</subject><subject>Drug Design</subject><subject>General aspects</subject><subject>Hydroxylation</subject><subject>Kinesin - antagonists & inhibitors</subject><subject>Kinesin - chemistry</subject><subject>Kinesin - metabolism</subject><subject>Medical sciences</subject><subject>Mitosis</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrazoles - chemical synthesis</subject><subject>Pyrazoles - chemistry</subject><subject>Pyrazoles - pharmacokinetics</subject><subject>Pyrazoles - pharmacology</subject><subject>Solubility</subject><subject>Structure-Activity Relationship</subject><subject>Water</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUctqFTEYDqLY0-oLuJBslArN-GeSycy4k-KNFixUwV1IMhlPTjOXJhnk-GK-njl24CxdJR98N_4PoRcUCgpUvN0VejC-KAFEAawADo_QhnLBCeNQPUYbaAWQpuU_TtBpjDsAyoHzp-iECgGMVWKD_ly50UY34ji7sfMWz2FKNuPzq9ubN9iNW6ddmkIs8I0KCfN3-DaFxaQlWKJVtB3usv7niKceV0T5u71Xgxsnwi4q0jkV9p7wf9_tvgvTvA_q9-RtxCriOUeN6QL_UskGEie_6NzgmHnwTFuLh4ySM_hu7ZqrPUNPeuWjfb6-Z-j7xw_fLj-T66-fvly-vyaGl00ipbCq0hxAK860AdNVPVN1b63lilVt2auyyxha3VMlyroySjNuRN0bZkvLztDrB998l_vFxiQHF431Xo12WqIUdcsaaJv_EmlNRVPXVSaWD0QTphiD7eUc3JDvJCnIw65yJw-7ysOuEpjMu2bRy9V90YPtjpJ1yEx4tRJUNMr3QY3GxSMvJzeNqNlfEgev3A</recordid><startdate>20060615</startdate><enddate>20060615</enddate><creator>COX, Christopher D</creator><creator>TORRENT, Maricel</creator><creator>LOBELL, Robert B</creator><creator>WEIKANG TAO</creator><creator>SOUTH, Vicki J</creator><creator>KOHL, Nancy E</creator><creator>YOUWEI YAN</creator><creator>KUO, Lawrence C</creator><creator>PRUEKSARITANONT, Thomayant</creator><creator>SLAUGHTER, Donald E</creator><creator>CHUNZE LI</creator><creator>MAHAN, Elizabeth</creator><creator>BRESLIN, Michael J</creator><creator>BING LU</creator><creator>HARTMAN, George D</creator><creator>MARIANO, Brenda J</creator><creator>WHITMAN, David B</creator><creator>COLEMAN, Paul J</creator><creator>BUSER, Carolyn A</creator><creator>WALSH, Eileen S</creator><creator>HAMILTON, Kelly</creator><creator>SCHABER, Michael D</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20060615</creationdate><title>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</title><author>COX, Christopher D ; TORRENT, Maricel ; LOBELL, Robert B ; WEIKANG TAO ; SOUTH, Vicki J ; KOHL, Nancy E ; YOUWEI YAN ; KUO, Lawrence C ; PRUEKSARITANONT, Thomayant ; SLAUGHTER, Donald E ; CHUNZE LI ; MAHAN, Elizabeth ; BRESLIN, Michael J ; BING LU ; HARTMAN, George D ; MARIANO, Brenda J ; WHITMAN, David B ; COLEMAN, Paul J ; BUSER, Carolyn A ; WALSH, Eileen S ; HAMILTON, Kelly ; SCHABER, Michael D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alkylation</topic><topic>Allosteric Site</topic><topic>Amination</topic><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Crystallography, X-Ray</topic><topic>Dogs</topic><topic>Drug Design</topic><topic>General aspects</topic><topic>Hydroxylation</topic><topic>Kinesin - antagonists & inhibitors</topic><topic>Kinesin - chemistry</topic><topic>Kinesin - metabolism</topic><topic>Medical sciences</topic><topic>Mitosis</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrazoles - chemical synthesis</topic><topic>Pyrazoles - chemistry</topic><topic>Pyrazoles - pharmacokinetics</topic><topic>Pyrazoles - pharmacology</topic><topic>Solubility</topic><topic>Structure-Activity Relationship</topic><topic>Water</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>COX, Christopher D</creatorcontrib><creatorcontrib>TORRENT, Maricel</creatorcontrib><creatorcontrib>LOBELL, Robert B</creatorcontrib><creatorcontrib>WEIKANG TAO</creatorcontrib><creatorcontrib>SOUTH, Vicki J</creatorcontrib><creatorcontrib>KOHL, Nancy E</creatorcontrib><creatorcontrib>YOUWEI YAN</creatorcontrib><creatorcontrib>KUO, Lawrence C</creatorcontrib><creatorcontrib>PRUEKSARITANONT, Thomayant</creatorcontrib><creatorcontrib>SLAUGHTER, Donald E</creatorcontrib><creatorcontrib>CHUNZE LI</creatorcontrib><creatorcontrib>MAHAN, Elizabeth</creatorcontrib><creatorcontrib>BRESLIN, Michael J</creatorcontrib><creatorcontrib>BING LU</creatorcontrib><creatorcontrib>HARTMAN, George D</creatorcontrib><creatorcontrib>MARIANO, Brenda J</creatorcontrib><creatorcontrib>WHITMAN, David B</creatorcontrib><creatorcontrib>COLEMAN, Paul J</creatorcontrib><creatorcontrib>BUSER, Carolyn A</creatorcontrib><creatorcontrib>WALSH, Eileen S</creatorcontrib><creatorcontrib>HAMILTON, Kelly</creatorcontrib><creatorcontrib>SCHABER, Michael D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>COX, Christopher D</au><au>TORRENT, Maricel</au><au>LOBELL, Robert B</au><au>WEIKANG TAO</au><au>SOUTH, Vicki J</au><au>KOHL, Nancy E</au><au>YOUWEI YAN</au><au>KUO, Lawrence C</au><au>PRUEKSARITANONT, Thomayant</au><au>SLAUGHTER, Donald E</au><au>CHUNZE LI</au><au>MAHAN, Elizabeth</au><au>BRESLIN, Michael J</au><au>BING LU</au><au>HARTMAN, George D</au><au>MARIANO, Brenda J</au><au>WHITMAN, David B</au><au>COLEMAN, Paul J</au><au>BUSER, Carolyn A</au><au>WALSH, Eileen S</au><au>HAMILTON, Kelly</au><au>SCHABER, Michael D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2006-06-15</date><risdate>2006</risdate><volume>16</volume><issue>12</issue><spage>3175</spage><epage>3179</epage><pages>3175-3179</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.</abstract><cop>Oxford</cop><pub>Elsevier</pub><pmid>16603356</pmid><doi>10.1016/j.bmcl.2006.03.040</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2006-06, Vol.16 (12), p.3175-3179 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_67938098 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Alkylation Allosteric Site Amination Animals Antineoplastic agents Biological and medical sciences Crystallography, X-Ray Dogs Drug Design General aspects Hydroxylation Kinesin - antagonists & inhibitors Kinesin - chemistry Kinesin - metabolism Medical sciences Mitosis Models, Molecular Molecular Structure Pharmacology. Drug treatments Pyrazoles - chemical synthesis Pyrazoles - chemistry Pyrazoles - pharmacokinetics Pyrazoles - pharmacology Solubility Structure-Activity Relationship Water |
title | Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A41%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinesin%20spindle%20protein%20(KSP)%20inhibitors.%20Part%204:%20Structure-based%20design%20of%205-alkylamino-3,5-diaryl-4,5-dihydropyrazoles%20as%20potent,%20water-soluble%20inhibitors%20of%20the%20mitotic%20kinesin%20KSP&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=COX,%20Christopher%20D&rft.date=2006-06-15&rft.volume=16&rft.issue=12&rft.spage=3175&rft.epage=3179&rft.pages=3175-3179&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2006.03.040&rft_dat=%3Cproquest_cross%3E67938098%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17168775&rft_id=info:pmid/16603356&rfr_iscdi=true |